Immunic, Inc.
IMUX· Nasdaq
IMUXImmunic, Inc.
Filed Feb 24, 2022 · 10-K · 55 days after period end · 0001280776-22-000006
| Metric | Q4 2021 | Q4 2020 | Q4 2019 | Q4 2018 |
|---|---|---|---|---|
| Net Income | -$21.19M | -$11.16M | -$7.69M | -$4.81M |
| EPS Diluted | -$0.81 | -$0.53 | -$0.75 | -$5.68 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Feb 24, 2022 · 55 d after period end
